跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 6,421 条关于
“VERAXA Biotech AG”
全部
6,421
临床试验
772
药物
1,135
机构
570
资讯
3,944
8个月前
Xlife Sciences Partners Twelve Biotech Companies with Grupo Landsteiner, Plans NASDAQ Listing for 2026
去年
VERAXA Biotech Appoints Oncology Veteran Rick Austin as Chief Scientific Officer to Advance Novel Cancer Therapies
去年
VERAXA Biotech and Voyager Acquisition to Merge, Creating $1.64B NASDAQ-Listed Cancer Therapeutics Company
9个月前
Veraxa Biotech's Nasdaq Listing Back on Track After US Government Shutdown Delays
去年
Tiprelestat Shows Promise in COVID-19 Patients: tiakis Biotech Announces Phase Ib/II Trial Results
去年
BRAIN Biotech AG Secures €128.88 Million Royalty Monetization Deal for Deucrictibant
上个月
Dr. Sven K. Weber Appointed CEO of BRAIN Biotech AG, Succeeding Adriaan Moelker
去年
Fabhalta Demonstrates Sustained Efficacy in Phase III C3 Glomerulopathy Trial
去年
Formycon's Aflibercept Biosimilar, AHZANTIVE®/Baiama®, Receives Positive CHMP Opinion for EU Approval
2年前
4SC AG Receives MHRA Waiver for Resminostat in Pediatric CTCL
第 1 页,共 395 页
上一页
下一页